SG Americas Securities’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Sell
296,782
-437,991
-60% -$28.8M 0.01% 615
2026
Q1
$52.3M Buy
734,773
+130,070
+22% +$10.3M 0.06% 273
2025
Q4
$49.6M Buy
604,703
+528,701
+696% +$41.2M 0.06% 237
2025
Q3
$5.71M Buy
76,002
+67,508
+795% +$5.04M 0.02% 462
2025
Q2
$629K Sell
8,494
-4,763
-36% -$332K ﹤0.01% 1492
2025
Q1
$1.07M Buy
13,257
+4,299
+48% +$369K ﹤0.01% 1121
2024
Q4
$700K Sell
8,958
-1,426
-14% -$121K ﹤0.01% 1073
2024
Q3
$975K Sell
10,384
-70,973
-87% -$5.96M ﹤0.01% 1104
2024
Q2
$6.34M Buy
81,357
+21,134
+35% +$1.72M 0.04% 452
2024
Q1
$5.47M Buy
60,223
+45,923
+321% +$3.82M 0.03% 520
2023
Q4
$1.11M Sell
14,300
-2,929
-17% -$205K 0.01% 971
2023
Q3
$1.17M Sell
17,229
-28,951
-63% -$2.11M 0.01% 1141
2023
Q2
$3.75M Buy
46,180
+41,705
+932% +$3.33M 0.03% 474
2023
Q1
$367K Buy
+4,475
New +$320K ﹤0.01% 1953

Other funds holding GEHC

SG Americas Securities's GEHC Position: Q2 2026 in Review

SG Americas Securities reduced its GE HealthCare (GEHC) stake by 60% in Q2 2026, selling an estimated $28.8M and leaving 296,782 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #615.

SG Americas Securities first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $52.3M in Q1 2026. 1,231 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • SG Americas Securities held 296,782 shares of GE HealthCare worth $19M as of Q2 2026.
  • SG Americas Securities sold 437,991 GE HealthCare shares in Q2 2026, an estimated $28.8M.
  • GE HealthCare made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #615 holding.
  • SG Americas Securities first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • SG Americas Securities's GE HealthCare position peaked at $52.3M in Q1 2026.
  • 1,231 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.